Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 13, 2007. The document serves as a notification of transactions involving directors and persons discharging managerial responsibility, specifically regarding changes in their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to disclosure of share transactions and does not contain financial performance data.
Material Changes
The material change disclosed is the purchase of Ordinary Shares by two individuals on July 12, 2007, under a Single Company ISA at a price of GBP 12.70 per share:
- Mr. J S Heslop: 5 shares
- Mr. A P Witty: 4 shares
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly adheres to the notification requirements of Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Investor Verification Points
- Verify the share price of GBP 12.70 per Ordinary Share on July 12, 2007.
- Confirm the total number of shares purchased by Mr. J S Heslop (5) and Mr. A P Witty (4).
- Ensure the transaction date (July 12, 2007) aligns with the notification date (July 13, 2007).